<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
NURESCELL INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.0001 PER SHARE
--------------------------------------------------------------------------------
(Title of Class of Securities)
67057R 101
----------------------------------
(CUSIP Number)
FEBRUARY 15, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 4 Pages
<PAGE>
13G
CUSIP No. 67057R 101 Page 2 of 4 Pages
-------------------------------------------------------------------------------
(1) Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Glenn A. Cramer
-------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) / /
-------------------------------------------------------------------------------
(3) SEC Use Only
-------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
-------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 1,050,000 shares
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 0 Shares
--------------------------------------------------
(7) Sole Dispositive Power
1,050,000 shares
--------------------------------------------------
(8) Shared Dispositive Power
0
-------------------------------------------------------------------------------
(9) Aggregate Amounts Beneficially Owned by Each Reporting Person
1,050,000 shares
-------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares* / /
-------------------------------------------------------------------------------
(11) Percent of Class Represented by Amounts in Row (9)
7.5%
-------------------------------------------------------------------------------
(12) Type of Reporting Person*
IN
-------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 4 Pages
<PAGE>
ITEM 1.
(a) Name of Issuer
Nurescell Inc.
---------------------------------------------------------------------
(b) Address of Issuer's Principal Executive Offices
1400 Bristol Street North, Suite 240
Newport Beach, California 92660
---------------------------------------------------------------------
ITEM 2.
(a) Name of Person Filing
Glenn A. Cramer
---------------------------------------------------------------------
(b) Address of Principal Business Office or, if none, Residence
3134 Bel Air Drive
Las Vegas, Nevada 89109
---------------------------------------------------------------------
(c) Citizenship
United States
---------------------------------------------------------------------
(d) Title of Class of Securities
Common Stock, par value $0.0001 per share
---------------------------------------------------------------------
(e) CUSIP Number
67057R 101
---------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13d-1(b) OR
240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
NOT APPLICABLE
ITEM 4. OWNERSHIP
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
1,030,000 shares
---------------------------------------------------------------------------
(b) Percent of class:
7.5%
---------------------------------------------------------------------------
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote
1,050,000 shares
-----------------------------------------------------------------
(ii) Shared power to vote or to direct the vote
0 shares
-----------------------------------------------------------------
(iii) Sole power to dispose or to direct the disposition of
1,050,000 shares
-----------------------------------------------------------------
(iv) Shared power to dispose or to direct the disposition of
0 shares
-----------------------------------------------------------------
Page 3 of 4 Pages
<PAGE>
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
NOT APPLICABLE
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
NOT APPLICABLE
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
NOT APPLICABLE
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
NOT APPLICABLE
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
NOT APPLICABLE
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATE: APRIL 24, 2000 /s/GLENN A. CRAMER
--------------------------------
GLENN A. CRAMER
Page 4 of 4 Pages
